Geneva Capital Management LLC cut its stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 8.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,284,888 shares of the business services provider’s stock after selling 120,285 shares during the period. Exponent comprises about 2.4% of Geneva Capital Management LLC’s holdings, making the stock its 14th biggest holding. Geneva Capital Management LLC owned 2.70% of Exponent worth $84,057,000 as of its most recent filing with the SEC.
A number of other large investors also recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. grew its position in shares of Exponent by 9.7% in the third quarter. Hantz Financial Services Inc. now owns 2,857 shares of the business services provider’s stock valued at $187,000 after purchasing an additional 253 shares during the period. Russell Investments Group Ltd. increased its stake in shares of Exponent by 78.5% during the third quarter. Russell Investments Group Ltd. now owns 28,013 shares of the business services provider’s stock worth $1,833,000 after purchasing an additional 12,317 shares in the last quarter. Hohimer Wealth Management LLC purchased a new stake in shares of Exponent during the third quarter worth about $221,000. Summit Creek Advisors LLC acquired a new position in shares of Exponent during the 3rd quarter worth about $2,520,000. Finally, Chicago Partners Investment Group LLC acquired a new position in shares of Exponent during the 3rd quarter worth about $226,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Exponent Price Performance
Exponent stock opened at $87.31 on Monday. Exponent, Inc. has a 52-week low of $51.91 and a 52-week high of $90.51. The firm has a market capitalization of $4.15 billion, a price-to-earnings ratio of 37.63 and a beta of 0.66. The company has a fifty day simple moving average of $73.30 and a 200-day simple moving average of $67.23.
Exponent (NASDAQ:EXPO – Get Free Report) last issued its earnings results on Thursday, October 29th. The business services provider reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.04. The business had revenue of $173.73 million during the quarter, compared to analysts’ expectations of $149.64 million. Exponent had a net margin of 17.40% and a return on equity of 34.61%. The company’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.55 earnings per share. On average, research analysts anticipate that Exponent, Inc. will post 2.36 EPS for the current fiscal year.
Exponent Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, December 4th. Exponent’s dividend payout ratio is currently 53.45%.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on EXPO. Zacks Research upgraded Exponent from a “hold” rating to a “strong-buy” rating in a report on Monday, November 2nd. JPMorgan Chase & Co. increased their target price on Exponent from $90.00 to $100.00 and gave the company an “overweight” rating in a report on Friday, October 30th. Weiss Ratings raised Exponent from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, November 9th. Finally, UBS Group raised their target price on Exponent from $72.00 to $82.00 and gave the company a “neutral” rating in a research report on Friday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $91.00.
View Our Latest Analysis on EXPO
Insider Buying and Selling
In other Exponent news, VP Richard Reiss sold 1,280 shares of the stock in a transaction dated Tuesday, November 3rd. The shares were sold at an average price of $86.44, for a total value of $110,643.20. Following the completion of the sale, the vice president owned 1,008 shares in the company, valued at approximately $87,131.52. This represents a 55.94% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.70% of the company’s stock.
Exponent Profile
Exponent, Inc. is a multidisciplinary engineering and scientific consulting firm that helps clients investigate complex technical issues and manage risk. Its consultants analyze incidents such as product failures and accidents, assess potential hazards, and provide expert advice on engineering, scientific, and regulatory matters. The company’s services span fields including engineering, materials science, environmental science, health, and data analytics. Clients use Exponent’s expertise for product development and testing, litigation support, regulatory compliance, and risk assessment across a range of industries.
Featured Stories
- Five stocks we like better than Exponent
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
